A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm, precancerous condition	Recruiting	Phase 1	2025-09-24		NCT06501196

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BlossomHill Therapeutics	2

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City of Hope Medical Center	Duarte	United States	313
Fred Hutchinson Cancer Center	Seattle	United States	250
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Moffitt Cancer Center	Tampa	United States	523
Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion	Chicago	United States	2
Roswell Park Cancer Institute	Buffalo	United States	382
Sarah Cannon Research Institute	Nashville	United States	119
Stanford Cancer Center	Palo Alto	United States	18
Sylvester Comprehensive Cancer Center	Miami	United States	37
The Ohio State University Wexner Medical Center - James Cancer Hosp	Columbus	United States	1
The University of Texas M.D. Anderson Cancer Center	Houston	United States	18
University of California Los Angeles	Los Angeles	United States	87
University of Wisconsin Clinical Science Center	Madison	United States	14